📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders. (2023)

First Author: Schmidt AF

Attributed to: Multimorbidity Mechanism and Therapeutics Research Collaborative funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.08.15.23293564

PubMed Identifier: 37645746

Publication URI: http://europepmc.org/abstract/MED/37645746

Type: Journal Article/Review

Parent Publication: medRxiv : the preprint server for health sciences